Results for tag: "Bronchiectasis"

Bronchiectasis is a chronic lung condition characterized by the abnormal widening of the bronchi, which can lead to recurrent infections and difficulty breathing. It is a common complication of cystic fibrosis, but can also be caused by other conditions such as autoimmune diseases, genetic disorders, and environmental factors. Treatment typically involves antibiotics, bronchodilators, and other medications to reduce inflammation and improve airway clearance. In some cases, surgery may be necessary to remove damaged tissue. The bronchiectasis market is an important part of pulmonary medicine, as it is estimated that over 10 million people worldwide suffer from the condition. The market is expected to grow in the coming years due to the increasing prevalence of bronchiectasis and the development of new treatments. Some companies in the bronchiectasis market include GlaxoSmithKline, AstraZeneca, Novartis, Boehringer Ingelheim, and Chiesi Pharmaceuticals. Show Less Read more